The role of the Histology Laboratory Core is to coordinate and provide professional and technical services for proper handling and processing of histopathologic materials.
Specific aims are: 1) to prepare routine hematoxylin and eosin (H&E)-stained pathology slides and provide histopathologic characteristics of biopsy materials; 2) to perform and core Ki-67 immunohistochemical staining on bronchial biopsy samples for Project 1; 3) to prepare and distribute unstained tissue sections required for special histopathologic examinations and in situ hybridization studies; 4) to assist in the interpretation and evaluation of biomarker analysis. The main purpose of this project is to develop effective chemopreventive approaches in current and former smokers and to identify potentially useful biomarkers of intermediate endpoints. We expect to deal with a large bulk of histopathologic materials in this project. In addition, some studies require special care in preparing the tissue sections. For example, for the in situ mRNA hybridization studies, the slide should be prepared using specially treated water to avoid RNA degradation, which cannot be accommodated by the regular pathology department personnel. Therefore, it is essential to establish a separate core facility for successful control of this project. As the clinical trial progresses to attain the targeted sample size, more core effort will be required in the preparation and distribution of tissue sections for the translational research projects. The role of this core will become increasingly important because proposed studies and further progress in the field of carcinogenesis research may identify new cellular, biochemical, or molecular genetic markers of interest. These will need to be tested and expanded using the tissue samples obtained through this project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA091844-02
Application #
6646626
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Yang, Peiying; Cartwright, Carrie; Efuet, Ekem et al. (2014) Cellular location and expression of Na+, K+ -ATPase ? subunits affect the anti-proliferative activity of oleandrin. Mol Carcinog 53:253-63
Gold, Kathryn A; Kim, Edward S; Liu, Diane D et al. (2014) Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy. Clin Cancer Res 20:1946-54
Gold, Kathryn A; Kim, Edward S; Wistuba, Ignacio I et al. (2013) Personalizing lung cancer prevention through a reverse migration strategy. Top Curr Chem 329:221-40
Lee, J Jack; Chu, Caleb T (2012) Bayesian clinical trials in action. Stat Med 31:2955-72
Gold, Kathryn A; Kim, Edward S; Lee, J Jack et al. (2011) The BATTLE to personalize lung cancer prevention through reverse migration. Cancer Prev Res (Phila) 4:962-72
Kunnumakkara, Ajaikumar B; Sung, Bokyung; Ravindran, Jayaraj et al. (2010) {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment. Cancer Res 70:8695-705
Aggarwal, Bharat B; Sundaram, Chitra; Prasad, Seema et al. (2010) Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol 80:1613-31
Ravindran, Jayaraj; Subbaraju, Gottumukkala V; Ramani, Modukuri V et al. (2010) Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro. Biochem Pharmacol 79:1658-66
Nair, Hareesh B; Sung, Bokyung; Yadav, Vivek R et al. (2010) Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 80:1833-43
Prasad, Sahdeo; Ravindran, Jayaraj; Sung, Bokyung et al. (2010) Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins. Mol Cancer Ther 9:856-68

Showing the most recent 10 out of 148 publications